Monitoring of potential Cardioprotective Effect of Midazolam (Pilot Study)
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F08%3A00007175" target="_blank" >RIV/61989592:15110/08:00007175 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Monitoring of potential Cardioprotective Effect of Midazolam (Pilot Study)
Original language description
Midazolam is a benzodiazepine derivative. It has powerful anxiolytic, amnestic, hypnotic, anticonvulsant, skeletal muscle relaxant and sedative properties. It is considered a fast-acting benzodiazepine, with a short elimination half-life. It is thereforea very useful drug to use for short minor procedures such as dental extraction. Midazolam was first synthesized in 1976 by Fryer and Walser.
Czech name
Testování potenciálního kardioprotektivního efektu midazolamu (pilotní studie)
Czech description
Cílem bylo testovat efekt midazolamu za podmínek ischemie-reperfuze srdce laboratorního potkana. Došlo ke zlepšení funkčních parametrů LVP, LVEDP a +dP/dt max.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Prague Medical Report
ISSN
1214-6994
e-ISSN
—
Volume of the periodical
109
Issue of the periodical within the volume
2
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
2
Pages from-to
—
UT code for WoS article
—
EID of the result in the Scopus database
—